FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3208292591> ?p ?o ?g. }

• W3208292591 endingPage "1280" @default.
• W3208292591 startingPage "1272" @default.
• W3208292591 abstract "Seroepidemiological studies provide important insight into the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV‑2) in our society. We aimed to determine seropositivity of SARS-CoV‑2 antibodies and its cross-sectional correlates in a large cohort of blood donors.In this observational cohort study, we tested healthy blood donors residing in Tyrol, Austria, for SARS-CoV‑2 antibodies using the Abbott SARS-CoV‑2 IgG chemiluminescent microparticle immunoassay. We estimated 95% confidence intervals (95% CI) of seroprevalences using bootstrapping and tested for differences by participant characteristics using logistic regression.Between 8 June and 4 September 2020, we screened 5345 healthy individuals at local blood donor sessions (mean age 42.7 years, SD 13.5 years, 46.7% female). Overall seroprevalence was 3.1% (95% CI 2.7-3.6%, 165 cases), which is 5.1-fold higher (95% CI 4.5-6.0%) than the case number identified by the health authorities in the state-wide testing program (0.6%; 4536 out of 757,634). Seroprevalence was higher in the district Landeck (16.6%, P < 0.001) and in individuals aged < 25 years (4.7%, P = 0.043), but did not differ by gender, blood types, or medication intake. The odds ratio for seropositivity was 2.51 for participants who had travelled to Ischgl (1.49-4.21, P = 0.001), 1.39 who had travelled to other federal states (1.00-1.93, P = 0.052), and 2.41 who had travelled abroad (1.61-3.63, P < 0.001). Compared to participants who had a suspected/confirmed SARS-CoV‑2 infection but were seronegative, seropositive participants more frequently reported loss of smell (odds ratio = 2.49, 1.32-4.68, P = 0.005) and taste (odds ratio = 2.76, 1.54-4.92, P = 0.001).In summer 2020, SARS-CoV‑2 seroprevalence in Tyrolean blood donors was 3.1%. Our study revealed regional variation and associations with young age, travel history and specific symptoms." @default.
• W3208292591 created "2021-11-08" @default.
• W3208292591 creator A5000941967 @default.
• W3208292591 creator A5009508675 @default.
• W3208292591 creator A5009628835 @default.
• W3208292591 creator A5018136553 @default.
• W3208292591 creator A5034070910 @default.
• W3208292591 creator A5044116629 @default.
• W3208292591 creator A5052971511 @default.
• W3208292591 creator A5054381281 @default.
• W3208292591 creator A5058789039 @default.
• W3208292591 creator A5069506755 @default.
• W3208292591 creator A5073110497 @default.
• W3208292591 creator A5074776782 @default.
• W3208292591 creator A5075874874 @default.
• W3208292591 creator A5091489143 @default.
• W3208292591 date "2021-10-26" @default.
• W3208292591 modified "2023-09-26" @default.
• W3208292591 title "Prevalence of SARS-CoV-2 antibodies in healthy blood donors from the state of Tyrol, Austria, in summer 2020" @default.
• W3208292591 cites W3008827533 @default.
• W3208292591 cites W3012285389 @default.
• W3208292591 cites W3012559827 @default.
• W3208292591 cites W3016078614 @default.
• W3208292591 cites W3021039517 @default.
• W3208292591 cites W3032774217 @default.
• W3208292591 cites W3034404517 @default.
• W3208292591 cites W3036173324 @default.
• W3208292591 cites W3037183278 @default.
• W3208292591 cites W3043138331 @default.
• W3208292591 cites W3046383041 @default.
• W3208292591 cites W3080261212 @default.
• W3208292591 cites W3087153161 @default.
• W3208292591 cites W3090015418 @default.
• W3208292591 cites W3090857960 @default.
• W3208292591 cites W3094968263 @default.
• W3208292591 cites W3106194960 @default.
• W3208292591 cites W3114250596 @default.
• W3208292591 cites W3122415311 @default.
• W3208292591 cites W3161136069 @default.
• W3208292591 cites W3171640455 @default.
• W3208292591 cites W3175666822 @default.
• W3208292591 cites W3196021221 @default.
• W3208292591 doi "https://doi.org/10.1007/s00508-021-01963-3" @default.
• W3208292591 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8546400" @default.
• W3208292591 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34698961" @default.
• W3208292591 hasPublicationYear "2021" @default.
• W3208292591 type Work @default.
• W3208292591 sameAs 3208292591 @default.
• W3208292591 citedByCount "7" @default.
• W3208292591 countsByYear W32082925912022 @default.
• W3208292591 countsByYear W32082925912023 @default.
• W3208292591 crossrefType "journal-article" @default.
• W3208292591 hasAuthorship W3208292591A5000941967 @default.
• W3208292591 hasAuthorship W3208292591A5009508675 @default.
• W3208292591 hasAuthorship W3208292591A5009628835 @default.
• W3208292591 hasAuthorship W3208292591A5018136553 @default.
• W3208292591 hasAuthorship W3208292591A5034070910 @default.
• W3208292591 hasAuthorship W3208292591A5044116629 @default.
• W3208292591 hasAuthorship W3208292591A5052971511 @default.
• W3208292591 hasAuthorship W3208292591A5054381281 @default.
• W3208292591 hasAuthorship W3208292591A5058789039 @default.
• W3208292591 hasAuthorship W3208292591A5069506755 @default.
• W3208292591 hasAuthorship W3208292591A5073110497 @default.
• W3208292591 hasAuthorship W3208292591A5074776782 @default.
• W3208292591 hasAuthorship W3208292591A5075874874 @default.
• W3208292591 hasAuthorship W3208292591A5091489143 @default.
• W3208292591 hasBestOaLocation W32082925911 @default.
• W3208292591 hasConcept C126322002 @default.
• W3208292591 hasConcept C142052008 @default.
• W3208292591 hasConcept C142724271 @default.
• W3208292591 hasConcept C144024400 @default.
• W3208292591 hasConcept C149923435 @default.
• W3208292591 hasConcept C151956035 @default.
• W3208292591 hasConcept C156957248 @default.
• W3208292591 hasConcept C159654299 @default.
• W3208292591 hasConcept C201903717 @default.
• W3208292591 hasConcept C203014093 @default.
• W3208292591 hasConcept C2778494684 @default.
• W3208292591 hasConcept C44249647 @default.
• W3208292591 hasConcept C45189115 @default.
• W3208292591 hasConcept C71924100 @default.
• W3208292591 hasConcept C72563966 @default.
• W3208292591 hasConceptScore W3208292591C126322002 @default.
• W3208292591 hasConceptScore W3208292591C142052008 @default.
• W3208292591 hasConceptScore W3208292591C142724271 @default.
• W3208292591 hasConceptScore W3208292591C144024400 @default.
• W3208292591 hasConceptScore W3208292591C149923435 @default.
• W3208292591 hasConceptScore W3208292591C151956035 @default.
• W3208292591 hasConceptScore W3208292591C156957248 @default.
• W3208292591 hasConceptScore W3208292591C159654299 @default.
• W3208292591 hasConceptScore W3208292591C201903717 @default.
• W3208292591 hasConceptScore W3208292591C203014093 @default.
• W3208292591 hasConceptScore W3208292591C2778494684 @default.
• W3208292591 hasConceptScore W3208292591C44249647 @default.
• W3208292591 hasConceptScore W3208292591C45189115 @default.
• W3208292591 hasConceptScore W3208292591C71924100 @default.
• W3208292591 hasConceptScore W3208292591C72563966 @default.
• W3208292591 hasIssue "23-24" @default.

• next